Aqemia

French drug discovery company in Paris, founded in 2019 out of research at the École Normale Supérieure, which combines statistical physics with machine learning to predict how strongly molecules bind their targets. Runs its own discovery programmes in oncology and immunology, generates and scores new molecules computationally before testing them in the laboratory, and works with pharmaceutical partners including Sanofi and Servier on discovery collaborations.